marginally significantp = 0.06
Anti-AMA1 antibodies showed a marginally significant association with increased malaria risk: for the secondary case definition, the adjusted IRR was 1.28 (95% CI: 0.97–1.71; p = 0.06), with a similar trend for the primary case definition (IRR = 1.36; p = 0.06).